JGC
MYOK

J. Goldman & Co’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

J. Goldman & Co’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6,021
Closed -$582K – 432
2020
Q2 		$582K Buy
+6,021
New +$502K 0.04% 211
2018
Q2 		– Sell
-14,874
Closed -$726K – 493
2018
Q1 		$726K Buy
+14,874
New +$773K 0.03% 274

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

J. Goldman & Co's MYOK Position: Q3 2020 in Review

J. Goldman & Co sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 6,021 shares — an estimated $582K sold.

J. Goldman & Co first reported a position in MYOK in Q1 2018 and held it in 2 quarters. The position peaked at $726K in Q1 2018. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

  • J. Goldman & Co reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • J. Goldman & Co sold 6,021 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $582K.
  • J. Goldman & Co first reported a position in MyoKardia, Inc. Common Stock in Q1 2018 and held it in 2 quarters.
  • J. Goldman & Co's MyoKardia, Inc. Common Stock position peaked at $726K in Q1 2018.
  • 237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on J. Goldman & Co's 13F filing for Q3 2020, filed 16 Nov 2020.